J. Kelly

Liver tissue engineering in the evaluation of drug safety

Walker Inman, R Scott Obach, Linda G Griffith, 2009, Expert opinion on drug metabolism & toxicology.

Assay for Glycosaminoglycans by Tandem Mass Spectrometry and its Applications

T. Shimada, Yasuyuki Suzuki, S. Yamaguchi, 2014, Journal of analytical & bioanalytical techniques.

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses

T. Shimada, R. Giugliani, Yasuyuki Suzuki, 2014, Metabolites.

Chemical and serological characterization of the Bordetella hinzii lipopolysaccharides 1

P. Thibault, J. Kelly, M. Perry, 2000, FEBS letters.

Title Establishment of glycosaminoglycan assays for mucopolysaccharidoses

T. Shimada, R. Giugliani, Yasuyuki Suzuki, 2017 .

NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.

A. Kalgutkar, R. Obach, D. Dalvie, 2007, Chemical research in toxicology.

Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction.

A. Kalgutkar, R. Obach, W. Lam, 2009, Chemical research in toxicology.

Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.

T. Shimada, R. Giugliani, Yasuyuki Suzuki, 2014, Molecular genetics and metabolism.